2020 Annual Business Report

Our Financials & Outlook

Financials & Outlook


We look forward to all that’s to come in 2021, as we continue building on our strengths to reimagine the future.

Financials & Outlook

Our Key Figures 2020 -Unaudited

2020 financial results reflect the downturn in the travel industry and the great progress made across our R&D pipeline.


Shareholder structure (January 2021)

Shareholder structure
Our capital strategy

Our capital strategy

Our capital strategy is a combination of non-dilutive funding sources and equity capital to finance the development of the Company’s vaccine candidates.

Financials & Outlook

2021 Outlook

In 2021, Valneva expects to achieve major R&D milestones while increasing R&D investments in its three late-stage product candidates.


Valneva’s financial reports